Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Be aware: That COVID-19 test kit in your home could contain a toxic substance that may be harmful to your children and you. The substance is sodium azide, and Cincinnati Children's Hospital Medical Center's Drug and Poison Information Center has seen a surge in calls about exposures to the chemical since more people started self-testing for COVID-19 at home. Fifty million U.S. households have received some version of the test kits, although it's not clear how many contain sodium azide. The government has sent 200 million of the kits, with about 85% of initial orders filled. The chemical is colorless, tasteless and odorless, and it is mainly used in car airbags and as a pest control agent. Ingesting it can cause low blood pressure, which can result in dizziness, headaches or palpitations. Exposure to it can also cause skin, eye or nostril irritation. Large amounts of exposure to sodium azide can cause severe health threats, leading to convulsions, loss of consciousness, lung injury, respiratory failure leading to death, the Centers of Disease Control and Prevention notes. "Sodium azide is a very potent poison, and ingestion of relatively low doses can cause significant toxicity," Poison Control said. "The extraction vials do look like small squeeze bottles. Some people may accidentally confuse them with medications." Several poison centers throughout the United States have reported sodium azide exposures from the COVID-19 test kits.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

In March, as coronavirus deaths in the UK began to mount, two hospitals in northeast England began taking vitamin D readings from patients and prescribing them with extremely high doses of the nutrient. Studies had suggested that having sufficient levels of vitamin D, which is created in the skin's lower layers through the absorption of sunlight, plays a central role in immune and metabolic function and reduces the risk of certain community-acquired respiratory illnesses. But the conclusions were disputed, and no official guidance existed. A French experimental study at a nursing home with 66 people suggested that taking regular vitamin D supplements was "associated with less severe Covid-19 and a better survival rate". A study of 200 people in South Korea suggested that vitamin D deficiency could "decrease the immune defences against Covid-19". Preliminary research by Queen Elizabeth Hospital foundation trust and the University of East Anglia found a correlation between European countries with low vitamin D levels and coronavirus infection rates. A Spanish study ... came close to incontrovertibly proving low vitamin D levels have a pivotal role in causing increased death rates. 50 patients with Covid-19 were given a high dose of vitamin D, while another 26 patients did not receive the nutrient. Half of patients who weren't given vitamin D had to be placed in intensive care, and two later died. Only one patient who received vitamin D required ICU admission, and they were later released.

Note: Because Vitamin D is cheap and does not benefit big Pharma, which is the biggest sponsor of the media, this effective treatment which could have saved many thousands of lives has gotten very little press. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

Dr. Seema Doshi was shocked and terrified when she found a lump in her breast that was eventually confirmed to be cancerous. "That rocked my world," said Dr. Doshi, a dermatologist in private practice. "I thought, ‘That's it. I will have to do chemotherapy.'" She was wrong. Dr. Doshi was the beneficiary of a quiet revolution in breast cancer treatment, a slow chipping away at the number of people for whom chemotherapy is recommended. Chemotherapy for decades was considered "the rule, the dogma," for treating breast cancer and other cancers, said Dr. Gabriel Hortobagyi, a breast cancer specialist. But data from a variety of sources offers some confirmation of what many oncologists say anecdotally – the method is on the wane for many cancer patients. Genetic tests can now reveal whether chemotherapy would be beneficial. For many there are better options with an ever-expanding array of drugs, including estrogen blockers and drugs that destroy cancers by attacking specific proteins on the surface of tumors. And there is a growing willingness among oncologists to scale back unhelpful treatments. The result spares thousands each year from the dreaded chemotherapy treatment, with its accompanying hair loss, nausea, fatigue, and potential to cause permanent damage to the heart and to nerves in the hands and feet. The diminution of chemotherapy treatment is happening for some other cancers, too, including lung cancer.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

A remote and unique indigenous population in the Bolivian Amazon called the Tsimane (pronounced chee-MAH-nay) sparked the interest of scientists when they were found to show almost no cases of age-related heart disease. Since then, scientists have carried out various studies into the Tsimane community due to their exceptional health even in old age. In 2017, researchers from The Tsimane Health and Life History Project were astonished to find that the elderly Tsimane experienced unusually low levels of vascular aging, and a study in The Lancet reported that the average 80-year-old Tsimane adult demonstrated the same vascular age as a 55-year-old American. Researchers are now looking into the brain health of the Tsimane community, in particular the prevalence of dementia. Only five cases of dementia were detected, which equates to about one percent of the population studied–significantly below the 11 percent of the equivalent American population known to be living with dementia. Researchers also studied 169 individuals hailing from the Moseten community, a community genetically and linguistically similar to the Tsimane. The Moseten also showed very low levels of dementia, even though they lived in closer proximity to modern Bolivian society. "Something about the pre-industrial subsistence lifestyle appears to protect older Tsimane and Moseten from dementia," says Margaret Gatz, lead author of the study.

Note: The profoundly inspiring documentary "Alive Inside" presents the astonishing experiences of elderly individuals with severe dementia who are revitalized through the simple experience of listening to music that meant something to them in their earlier years. Featuring experts including renowned neurologist/best-selling author Oliver Sacks and musician Bobby McFerrin, this beautiful portrait of senile patients coming back to life was the winner of Sundance Film Festival Audience Award.

Canadian pharmaceutical company SaNOtize Research & Development Corp., (SaNOtize), and Glenmark Pharmaceuticals Limited (Glenmark), a global, innovation-driven pharmaceutical company, today announced successful results of Phase 3 clinical trials and approval from India's drug regulator for the treatment of adult patients with COVID-19 who have a risk of progression of the disease. The study confirmed that SaNOtize's Nitric Oxide Nasal Spray (NONS) represents a safe and effective antiviral treatment that shortens the course of COVID-19, and could prevent the transmission of COVID-19. In a randomized, double-blind, placebo-controlled, parallel-arm study ... NONS reduced the SARS-CoV-2 log viral load in COVID-19 patients by more than 94% within 24 hours of treatment, and by more than 99% in 48 hours as compared to saline control. Treatment also demonstrated ... a statistically significant greater proportion of patients who achieved a combination of clinical and virological cure, based on the World Health Organization (WHO) Progression Scale. Moreover, the median time to negative PCR, in this group, was 4 days in the treatment group compared with 8 days in the control. Test subjects included patients infected with different variants, likely including Delta and Omicron. There were no significant adverse health events recorded. The reduction in log viral load corroborates the reduction of viral load in the UK Phase 2 trials (a reduction of 95% in 24 hours and 99% in 72 hours), conducted in March 2021.

Note: Why isn't this getting major attention in the media? Could it be because big Pharma will lose billions of dollars if this goes global? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Promotion of influenza vaccines is one of the most visible and aggressive public health policies today. Twenty years ago, in 1990, 32 million doses of influenza vaccine were available in the United States. Today around 135 million doses of influenza vaccine annually enter the US market, with vaccinations administered in drug stores, supermarkets–even some drive-throughs. This enormous growth has not been fueled by popular demand but instead by a public health campaign that delivers a straightforward ... message: influenza is a serious disease, we are all at risk of complications from influenza, the flu shot is virtually risk free, and vaccination saves lives. Yet across the country, mandatory influenza vaccination policies have cropped up, particularly in healthcare facilities, precisely because not everyone wants the vaccination, and compulsion appears the only way to achieve high vaccination rates. Closer examination of influenza vaccine policies shows that although proponents employ the rhetoric of science, the studies underlying the policy are often of low quality, and do not substantiate officials' claims. The vaccine might be less beneficial and less safe than has been claimed, and the threat of influenza appears overstated. Since 2000, the concept of who is "at risk" has rapidly expanded, incrementally encompassing greater swathes of the general population. Today, national guidelines call for everyone 6 months of age and older to get vaccinated. Now we are all "at risk."

Note: Full text available here. For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.

In the Arctic, microscopic particles of plastic are falling out of the sky with snow. Scientists said they were shocked by the sheer number of particles they found: more than 10,000 of them per litre in the Arctic. Even there, people are likely to be breathing in microplastics from the air. The health implications remain unclear. The region is often seen as one of the world's last pristine environments. A German-Swiss team of researchers has published the work in the journal Science Advances. The scientists also found rubber particles and fibres in the snow. Researchers collected snow samples from the Svalbard islands. In the laboratory ... they discovered far more contaminating particles than they'd expected. Many were so small that it was hard to ascertain where they had come from. The majority appeared to be composed of natural materials like plant cellulose and animal fur. But there were also particles of plastic, along with fragments of rubber tyres, varnish, paint and possibly synthetic fibres. The lead scientist, Dr Melanie Bergmann, told BBC News: "We expected to find some contamination but to find this many microplastics was a real shock." She said: "The majority of the microplastic in the snow comes from the air." Microplastics are defined as those particles below 5mm in size. Addressing their potential effects on people, Dr Bergmann explained: "We don't know if the plastics will be harmful to human health or not. But we need to take much better care of the way we're treating our environment."

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

Henry Dryer sits slumped over the tray attached to his wheelchair. He doesn't speak, and rarely moves, until a nursing home worker puts his headphones on. Then Dryer's feet start to shuffle, his folded arms rock back and forth, and he sings out loud in perfect sync with his favorite songs. "I feel a band of love, dreams," said Dryer, 92, who has dementia. "It gives me the feeling of love, romance!" Henry is one of seven patients profiled in the documentary "Alive Inside," a heartwarming look at the power of music to help those in nursing homes. "There are a million and a half people in nursing homes in this country," director Michael Rossato-Bennett told ABC News. "When I saw what happened to Henry, whenever you see a human being awaken like that, it touches something deep inside you." Rossato-Bennett said he took on the documentary project to promote Music & Memory, a nonprofit organization that brings iPods with personalized music to dementia patients in nursing home care. "When I end up in a nursing home, I'll want to have my music with me," said Dan Cohen, executive director of Music & Memory. "There aren't many things in nursing homes that are personally meaningful activities. Here's the one easy thing that has a significant impact." Cohen said the personalized playlists, chosen by loved ones, make patients light up. "They're more alert, more attentive, more cooperative, more engaged," he said. "Even if they can't recognize loved ones and they've stopped speaking, they hear music and they come alive."

Note: Don't miss this profoundly touching and inspiring documentary available here. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Henry Dryer, 92, is one of seven patients profiled in the documentary Alive Inside, a look at the power of music to help those with Alzheimer's. A clip of Dryer, who suffers from dementia, appears in an extraordinarily moving rough cut of the documentary that went up online this week. In the clip, which has been viewed 3 million times already, Dryer is largely mute and slumped over. He does not recognize his own daughter. But when a caregiver places a pair [of] headphones on him, he undergoes an astonishing transformation. His face, formerly slack and inert, lights up. His eyes beam, and he sways in his chair, keening along to the music of his youth. The effect lasts even after the headphones are removed. "I'm crazy about music," Dryer says. "I guess Cab Calloway was my number one band guy." Music "gives me the feeling of love", Dryer says. Author and neurologist Oliver Sacks, who has written extensively about the effects of music on the human brain, watches Dryer. "In some sense, Henry is restored to himself. He remembers who he is. He has reaquired his identity for a while through the power of music," Sacks says in the Alive Inside clip. "There are a million and a half people in nursing homes in this country," Alive Inside director Michael Rossato-Bennett told ABC News. "When I saw what happened to Henry, whenever you see a human being awaken like that, it touches something deep inside you."

Note: Don't miss this profoundly touching and inspiring documentary available here. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Four African countries have reported new cases of polio linked to the oral vaccine, as global health numbers show there are now more children being paralyzed by viruses originating in vaccines than in the wild. In a report late last week, the World Health Organization and partners noted nine new polio cases caused by the vaccine in Nigeria, Congo, Central African Republic and Angola. Seven countries elsewhere in Africa have similar outbreaks and cases have been reported in Asia. Of the two countries where polio remains endemic, Afghanistan and Pakistan, vaccine-linked cases have been identified in Pakistan. In rare cases, the live virus in oral polio vaccine can mutate into a form capable of sparking new outbreaks. All the current vaccine-derived polio cases have been sparked by a Type 2 virus contained in the vaccine. Type 2 wild virus was eliminated years ago. WHO and partners have long relied on oral polio vaccines because they are cheap and can be easily administered. Western countries use a more expensive injectable polio vaccine that contains an inactivated virus incapable of causing polio. The Independent Monitoring Board, a group set up by WHO to assess polio eradication, warned in a report this month that vaccine-derived polio virus is "spreading uncontrolled in West Africa." The group said officials were already "failing badly" to meet a recently approved polio goal of stopping all vaccine-derived outbreaks within 120 days of detection.

Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.

Depression among adults in the United States tripled in the early 2020 months of the global coronavirus pandemic–jumping from 8.5 percent before the pandemic to a staggering 27.8 percent. New research from Boston University School of Public Health reveals that the elevated rate of depression has persisted into 2021, and even worsened, climbing to 32.8 percent and affecting 1 in every 3 American adults. The study is the first nationally representative study in the US that examines the change in depression prevalence before and then during the pandemic. Published in the journal The Lancet Regional Health–Americas, the study found that the most significant predictors for if a person experienced depressive symptoms during the pandemic were low household income, not being married, and experiencing multiple pandemic-related stressors. "The sustained high prevalence of depression does not follow [the same] patterns [we observed] after previous traumatic events, such as Hurricane Ike," says study senior author Sandro Galea. "Typically, we would expect depression to peak following the traumatic event and then lower over time. Instead, we found that 12 months into the pandemic, levels of depression remained high." The burden of depression intensified over the course of the pandemic and disproportionately impacted adults with lower incomes. By spring 2021, low-income adults were 7 times more likely to experience [elevated depressive] symptoms.

Note: Note that this huge increase in depression was caused not directly by the pandemic, but more by the isolation of the lockdown measures instituted. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

Did you ever feel your own shoulders relax when you saw a friend receive a shoulder massage? For those of you who said "yes," congratulations, your brain is using its power to create a "placebo effect." For those who said "no," you're not alone, but thankfully, the brain is trainable. Since the 1800s, the word placebo has been used to refer to a fake treatment, meaning one that does not contain any active, physical substance. Today, placebos play a crucial role in medical studies in which some participants are given the treatment containing the active ingredients of the medicine, and others are given a placebo. These types of studies help tell researchers which medicines are effective, and how effective they are. Surprisingly, however, in some areas of medicine, placebos themselves provide patients with clinical improvement. Research suggests that the placebo effect is caused by positive expectations, the provider-patient relationship and the rituals around receiving medical care. Depression, pain, fatigue, allergies, irritable bowel syndrome, Parkinson's disease and even osteoarthritis of the knee are just a few of the conditions that respond positively to placebos. In addition to the ever-increasing body of evidence surrounding their effectiveness, placebos offer multiple benefits. They have no side effects. They are cheap. They are not addictive. They provide hope when there might not be a specific chemically active treatment available. They mobilize a person's own ability to heal through multiple pathways.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Like many paediatricians, Dani Dumitriu braced herself for the impact of the SARS-CoV-2 coronavirus when it first surged in her wards. She was relieved when most newborn babies at her hospital who had been exposed to COVID-19 seemed to do just fine. But hints of a more subtle and insidious trend followed close behind. Dumitriu and her team ... had more than two years of data on infant development – since late 2017, they had been analysing the communication and motor skills of babies up to six months old. Dumitriu thought it would be interesting to compare the results from babies born before and during the pandemic. The infants born during the pandemic scored lower, on average, on tests of gross motor, fine motor and communication skills compared with those born before it. It didn't matter whether their birth parent had been infected with the virus or not; there seemed to be something about the environment of the pandemic itself. Lockdowns ... have isolated many young families, robbing them of playtime and social interactions. Stressed out and stretched thin, many carers also haven't been able to provide the one-to-one time that babies and toddlers need. Worryingly, [biophysicist Sean] Deoni has found that the longer the pandemic has continued, the more deficits children have accumulated. "The magnitude is massive – it's just astonishing," Deoni says of the findings, which are now under revision in JAMA Pediatrics.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

Inspired by a parasitic worm that digs its sharp teeth into its host's intestines, Johns Hopkins researchers have designed tiny, star-shaped microdevices that can latch onto intestinal mucosa and release drugs into the body. David Gracias, a professor in the Whiting School of Engineering, and gastroenterologist Florin M. Selaru, director of the Johns Hopkins Inflammatory Bowel Disease Center, led a team of researchers and biomedical engineers that designed and tested shape-changing microdevices that mimic the way the parasitic hookworm affixes itself to an organism's intestines. The "theragrippers" are made of metal and a thin, shape-changing film, then coated in heat-sensitive paraffin wax. The devices, each roughly the size of a dust speck, can potentially carry any drug and release it gradually into the body. Thousands of theragrippers can be deployed in the GI tract. When the paraffin wax coating on the grippers reaches the temperature inside the body, the devices close autonomously and clamp onto the colonic wall. The closing action causes the tiny, six-pointed devices to dig into the mucosa and remain attached to the colon, where they are retained and release their medicine payloads gradually into the body. Theragrippers, says Gracias, don't rely on electricity, wireless signals or external controls. "Instead, they operate like small, compressed springs with a temperature-triggered coating on the devices that releases the stored energy autonomously."

Note: These tiny devices are literally the size of a speck of dust. They can easily be hidden in a cotton swab and administered without a person's knowledge. Might they even be put in a vaccine and go undetected? For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

COVID-19 is a global pandemic. Treatment with hydroxychloroquine (HCQ), zinc, and azithromycin (AZM), also known as the Zelenko protocol, and treatment with intravenous (IV) vitamin C (IVC) have shown encouraging results in a large number of trials worldwide. In addition, vitamin D levels are an important indicator of the severity of symptoms in patients with COVID-19. Hospitalized patients with COVID-19 ... were screened for eligibility and randomly allocated to receive either HCQ, AZM, and zinc (group 1) or HCQ, AZM, zinc plus IV vitamin C treatment (group 2) for 14 days. The patients also received nontherapeutic levels of vitamin D3. A total of 237 hospitalized patients with COVID-19 ... were enrolled in the study. Almost all patients were vitamin D deficient (97%). All but one patient (99.6%; n = 236/237) treated with HCQ, AZM, and zinc with or without high-dose IV vitamin C (IVC) fully recovered. Additional IVC therapy contributed significantly to a quicker recovery (15 days versus 45 days until discharge; p = 0.0069). Low vitamin D levels were significantly correlated with a higher probability of admission to the intensive care unit (ICU) and longer hospital stay. Our study suggests that the treatment protocol of HCQ, AZM, and zinc with or without vitamin C is safe and effective in the treatment of COVID-19, with high dose IV vitamin C leading to a significantly quicker recovery.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Massachusetts health officials on Tuesday reported ... 290 more deaths in people with breakthrough cases. In the last week, 27,530 new breakthrough cases - infections in people who have been vaccinated - were reported, with 555 more vaccinated people hospitalized over the period. It's a 40% drop in the rate of new breakthrough cases in Massachusetts - the previous week saw 46,092 new COVID infections in vaccinated people. On Tuesday ... there were 127 new deaths reported -- a statistic that includes three days because of the weekend -- bringing the death toll to 21,546. The seven-day average test positivity stands at 7.13%. In December, Massachusetts Department of Public Health officials released a study that found that 97% of breakthrough cases in the state did not become severely ill and rarely led to deaths, especially among young people. Massachusetts' COVID metrics, tracked on the Department of Public Health's interactive coronavirus dashboard, have been trending downward after spiking to heights not seen since previous surges, a peak thought to be driven at least in part by the omicron variant.

Note: As of Jan. 31, 2022, Massachusetts had a total of 21,546 COVID deaths as reported above. Their first COVID death was on Mar. 20, 2020. So over the 97 weeks since the start of the pandemic, they averaged 222 deaths a week. Yet in the last week of January 2022, this NBC article reports 290 breakthrough deaths. So the number of deaths among the vaccinated in that one week was greater than the average weekly number of deaths for the whole pandemic. Weren't these vaccines supposed to be 90% effective or more?

In May, a long-awaited randomized, double-blind, placebo-controlled, Phase 3 clinical trial testing MDMA-assisted therapy for the treatment of PTSD was published in Nature Medicine. The trial was conducted by MAPS Public Benefit Corporation, a for-profit subsidiary launched by the registered non-profit in 2014, with the goal of conducting the necessary research to make MDMA a legally available medicine. "We are a for-profit, but we're wholly owned. We only have one shareholder, and it's a non-profit," says CEO Amy Emerson. While a non-profit is tax exempt and operates for charity, the PBC, like a traditional corporation, pays taxes, operates for profit, and has shareholders and stocks. The results of the Phase 3 clinical trial conducted by MAPS PBC revealed that after receiving a combination of talk therapy and MDMA, 67 percent of participants who received the drug no longer met the diagnostic criteria for PTSD, compared to 32 percent of participants who received the placebo. The trial was recently acknowledged as a "big win for the field" in Science Magazine's annual Breakthrough of the Year awards. "In our three-session model, there's no follow-up medication needed," [MAPS CMO Dr. Corine de Boer] says. After pooling the data of six Phase 2 trials together, de Boer's team found that 57 percent of participants no longer met the criteria for PTSD. At a one-year follow-up during which no MDMA was administered, that number increased to 67 percent.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.

McMaster Children's Hospital says it has seen a steady increase of youth in crisis since the COVID-19 pandemic began. Youth admitted for medical support after a suicide attempt has tripled over a four-month period, compared to last year. The hospital also said that patients are staying in hospital longer due to more serious attempts. A large number of these youth have reported COVID-related issues such as lack of social interaction, increased conflict at home, and the inability to rely on friends as main contributors. Over the same time period, youth admitted with substance use disorders has doubled compared to last year. In particular, the use of potentially deadly opioids has increased. The number of cases admitted to hospital with predominant symptoms of psychosis has doubled, with the large majority related to substance use. Meanwhile, McMaster Children's Hospital says referrals to its Eating Disorders Program have increased by 90 per cent in a four-month period, compared to last year. Admissions are projected to increase by 33 per cent over the 12-months since the pandemic started. "It's unprecedented," says clinical manager Paul Agar.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

European Union regulators warned that frequent Covid-19 booster shots could adversely affect the immune response and may not be feasible. Repeat booster doses every four months could eventually weaken the immune response and tire out people, according to the European Medicines Agency. Instead, countries should leave more time between booster programs and tie them to the onset of the cold season in each hemisphere, following the blueprint set out by influenza vaccination strategies, the agency said. The advice comes as some countries consider the possibility of offering people second booster shots in a bid to provide further protection against surging omicron infections. Earlier this month Israel became the first nation to start administering a second booster, or fourth shot, to those over 60. The U.K. has said that boosters are providing good levels of protection and there is no need for a second booster shot at the moment, but will review data as it evolves. Boosters "can be done once, or maybe twice, but it's not something that we can think should be repeated constantly," Marco Cavaleri, the EMA head of biological health threats and vaccines strategy, said at a press briefing on Tuesday. "We need to think about how we can transition from the current pandemic setting to a more endemic setting."

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Pregnant women have long been assured that acetaminophen can treat their aches, pains and fevers without bringing harm to the babies they carry. Now researchers say they have found a strong link between prenatal use of the medication and cases of attention-deficit hyperactivity disorder in children. The results, published ... in the journal JAMA Pediatrics, add to growing evidence that the active ingredient in Tylenol may influence brain development in utero. But they do not provide clear answers for mothers-to-be or their doctors about whether acetaminophen is safe during pregnancy. In analyzing data on more than 64,000 Danish women and their children, researchers found that kids whose mothers took the painkiller at any point during pregnancy were 29% more likely to be diagnosed with ADHD than were kids whose mothers took none. The risk increased the most – by 63% – when acetaminophen was taken during the second and third trimesters, and by 28% when used in the third trimester alone. But when taken only in the first trimester, the added risk was 9%. Members of the research team had long suspected that acetaminophen may behave as an endocrine-disrupting chemical capable of influencing fetal brain development. The drug is known to cross the placental barrier between mother and fetus, and some studies have found higher rates of male babies with undescended testicles born to women who took it during pregnancy.

Note: Another study on Tylenol found a two-fold increase in risk of children being born with both ADHD and autism. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.